메뉴 건너뛰기
International Journal of Radiation Oncology Biology Physics
Volumn 72, Issue 3, 2008, Pages 958-959
Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: In Regard to Safran et al. (Int J Radiat Oncol Biol Phys 2008;70:391-395)
Author keywords

[No Author keywords available]
Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL;
EID: 52949133039     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.05.070     Document Type: Letter
Times cited : (2)
References (5)
  • 1
    • 38149088836 scopus 로고    scopus 로고
    • Cetuximab with concurrent chemoradiation for esophagogastric cancer: Assessment of toxicity
    • Safran H., Suntharalingam M., Dipetrillo T., et al. Cetuximab with concurrent chemoradiation for esophagogastric cancer: Assessment of toxicity. Int J Radiat Oncol Biol Phys 70 (2008) 391-395
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 391-395
    • Safran, H.1    Suntharalingam, M.2    Dipetrillo, T.3
  • 2
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
    • (1989) Control Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 3
    • 33644971314 scopus 로고    scopus 로고
    • Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase I study of a new combined modality paradigm
    • Pfister D.G., Su Y.B., Kraus D.H., et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase I study of a new combined modality paradigm. J Clin Oncol 24 (2006) 1072-1078
    • (2006) J Clin Oncol , vol.24 , pp. 1072-1078
    • Pfister, D.G.1    Su, Y.B.2    Kraus, D.H.3
  • 4
    • 33847156303 scopus 로고    scopus 로고
    • Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
    • Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 8 (2007) 226-234
    • (2007) Lancet Oncol , vol.8 , pp. 226-234
    • Gebski, V.1    Burmeister, B.2    Smithers, B.M.3
  • 5
    • 0026769381 scopus 로고
    • Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
    • Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
    • (1992) N Engl J Med , vol.326 , pp. 1593-1598
    • Herskovic, A.1    Martz, K.2    Al-Sarraf, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.